Advancement in high-throughput next-generation sequencing along with mass-spectrometry-based proteomics offers a bridge between mutational landscapes to variant proteins. An integrated proteogenomic approach, including analysis of post-translational modifications unravels the links between altered mutational landscape, the proteome in a cancer and generate testable hypotheses about cancer progression and evolution.